To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·03-06 07:13
      ARKG Investment Tracker position change: Increased position in Twist Bioscience Corp by 7,524 shares, the number of shares held increased 0.38% compared to the previous period and now represents 8.25% of the total position.
      13Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-06 07:13
      ARKG Investment Tracker position change: Decreased position in Amgen by 38,548 shares, the number of shares held decreased 96.6% compared to the previous period and now represents 0.045% of the total position.
      30Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-06 07:13
      ARKG Investment Tracker position change: Increased position in Tempus AI by 119,447 shares, the number of shares held increased 6.46% compared to the previous period and now represents 8.91% of the total position.
      42Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-06 07:13
      ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 8,055 shares, the number of shares held increased 0.38% compared to the previous period and now represents 5.15% of the total position.
      64Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-06 07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 7,593 shares, the number of shares held increased 0.38% compared to the previous period and now represents 2.23% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-06 07:13
      ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 19,096 shares, the number of shares held decreased 96.69% compared to the previous period and now represents 0.027% of the total position.
      117Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-06 07:13
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 39,930 shares, the number of shares held increased 0.38% compared to the previous period and now represents 1.43% of the total position.
      4.94K1
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-06 07:13
      ARKG Investment Tracker position change: Opened position in Eli Lilly by 12,181 shares and now represents 1.08% of the total position.
      102Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-06 07:13
      ARKG Investment Tracker position change: Increased position in 10x Genomics, Inc. by 11,784 shares, the number of shares held increased 0.38% compared to the previous period and now represents 6.27% of the total position.
      21Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-06 07:13
      ARKG Investment Tracker position change: Increased position in Illumina by 1,422 shares, the number of shares held increased 0.38% compared to the previous period and now represents 4.34% of the total position.
      0Comment
      Report
    • empty
      No following yet
       
       
       
       

      Most Discussed